Mar 5, 2026 07:30AM
Mar 4, 2026 05:05PM
Feb 24, 2026 04:01PM
Feb 11, 2026 05:00PM
Feb 11, 2026 05:00PM
Feb 9, 2026 06:37AM
Feb 6, 2026 02:00AM Biogen earnings preview Q4: set for weaker print, Leqembi outlook in focus
Feb 4, 2026 04:01PM
Feb 4, 2026 07:30AM
Feb 4, 2026 07:30AM
Jan 28, 2026 07:30AM
Jan 28, 2026 07:30AM
Jan 25, 2026 11:52PM
Jan 25, 2026 06:30PM FDA accepts LEQEMBI IQLIK application for weekly Alzheimer's treatment
Jan 25, 2026 06:30PM
Jan 12, 2026 11:06AM
Jan 12, 2026 11:05AM
Jan 11, 2026 02:00PM
Jan 11, 2026 02:00PM
Dec 5, 2025 09:01AM
Dec 5, 2025 09:00AM Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 America
Dec 5, 2025 09:00AM
Dec 3, 2025 06:10PM
Dec 2, 2025 04:41PM
Dec 2, 2025 04:40PM
Dec 1, 2025 07:31AM
Dec 1, 2025 07:30AM
Nov 26, 2025 06:03AM Eisai completes FDA submission for LEQEMBI subcutaneous starting dose
Nov 25, 2025 07:31AM
Nov 25, 2025 07:30AM
Nov 20, 2025 07:30AM
Nov 17, 2025 06:02AM
Nov 17, 2025 06:00AM
Nov 16, 2025 03:00PM
Nov 14, 2025 04:05PM Biogen completes acquisition of Alcyone Therapeutics
Nov 14, 2025 04:05PM
Oct 31, 2025 03:37AM
Oct 13, 2025 07:30PM
Oct 9, 2025 04:31PM
Oct 9, 2025 04:30PM
Oct 9, 2025 04:30PM
Oct 6, 2025 04:30PM Eisai and Biogen launch at-home injection option for alzheimer's drug
Oct 6, 2025 04:30PM
Oct 6, 2025 04:30PM
Sep 26, 2025 06:00AM
Sep 23, 2025 04:30PM
Sep 23, 2025 04:30PM
Sep 18, 2025 07:40AM
Sep 18, 2025 07:40AM Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates
Sep 17, 2025 04:30PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All